These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38497450)

  • 1. Development of human endogenous retrovirus type K- related treatments for human diseases.
    Dai L; Fan J; Qin Z
    J Med Virol; 2024 Mar; 96(3):e29532. PubMed ID: 38497450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Endogenous Retrovirus K (HML-2) in Health and Disease.
    Xue B; Sechi LA; Kelvin DJ
    Front Microbiol; 2020; 11():1690. PubMed ID: 32765477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Human Endogenous Retrovirus-K-Encoded Np9 in Human Diseases: A Small Protein with Big Functions.
    Fan J; Qin Z
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions.
    Costa B; Vale N
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity.
    Liu M; Jia L; Li H; Liu Y; Han J; Wang X; Li T; Li J; Zhang B; Zhai X; Yu C; Li L
    Microbiol Spectr; 2022 Aug; 10(4):e0048522. PubMed ID: 35867400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of human endogenous retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers.
    Grabski DF; Ratan A; Gray LR; Bekiranov S; Rekosh D; Hammarskjold ML; Rasmussen SK
    J Pediatr Surg; 2021 Feb; 56(2):286-292. PubMed ID: 32682541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.
    Dembny P; Newman AG; Singh M; Hinz M; Szczepek M; Krüger C; Adalbert R; Dzaye O; Trimbuch T; Wallach T; Kleinau G; Derkow K; Richard BC; Schipke C; Scheidereit C; Stachelscheid H; Golenbock D; Peters O; Coleman M; Heppner FL; Scheerer P; Tarabykin V; Ruprecht K; Izsvák Z; Mayer J; Lehnardt S
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human endogenous retrovirus-K by antiretroviral drugs.
    Tyagi R; Li W; Parades D; Bianchet MA; Nath A
    Retrovirology; 2017 Mar; 14(1):21. PubMed ID: 28330477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Infection of Primary CD4
    Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing.
    Xue B; Zeng T; Jia L; Yang D; Lin SL; Sechi LA; Kelvin DJ
    Retrovirology; 2020 May; 17(1):10. PubMed ID: 32375827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of endogenous retroviruses-K in human cancer.
    Salavatiha Z; Soleimani-Jelodar R; Jalilvand S
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 32734655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human endogenous retrovirus family HERV-K(HML-3).
    Mayer J; Meese EU
    Genomics; 2002 Sep; 80(3):331-43. PubMed ID: 12213204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3.
    Padmanabhan Nair V; Liu H; Ciceri G; Jungverdorben J; Frishman G; Tchieu J; Cederquist GY; Rothenaigner I; Schorpp K; Klepper L; Walsh RM; Kim TW; Cornacchia D; Ruepp A; Mayer J; Hadian K; Frishman D; Studer L; Vincendeau M
    Cell Stem Cell; 2021 Sep; 28(9):1566-1581.e8. PubMed ID: 33951478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2).
    Lavie L; Kitova M; Maldener E; Meese E; Mayer J
    J Virol; 2005 Jan; 79(2):876-83. PubMed ID: 15613316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.
    Hohn O; Hanke K; Bannert N
    Front Oncol; 2013 Sep; 3():246. PubMed ID: 24066280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of an infectious human endogenous retrovirus.
    Lee YN; Bieniasz PD
    PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
    Robinson LR; Whelan SP
    J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.
    Gonzalez-Hernandez MJ; Swanson MD; Contreras-Galindo R; Cookinham S; King SR; Noel RJ; Kaplan MH; Markovitz DM
    J Virol; 2012 Aug; 86(15):7790-805. PubMed ID: 22593154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Insight on Activation of Human Endogenous Retroviruses (HERVs) in Malignant Melanoma upon Exposure to CuSO4.
    Karimi A; Sheervalilou R; Kahroba H
    Biol Trace Elem Res; 2019 Sep; 191(1):70-74. PubMed ID: 30539386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.
    Freimanis G; Hooley P; Ejtehadi HD; Ali HA; Veitch A; Rylance PB; Alawi A; Axford J; Nevill A; Murray PG; Nelson PN
    Clin Exp Immunol; 2010 Jun; 160(3):340-7. PubMed ID: 20345981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.